PEN (Penumbra) Quarterly Revenue Growth

Graphic logo of penumbrainc.com (PEN)

Should there be concerns regarding regulatory barriers and supply chain disruptions for Penumbra, Inc. (PEN)? The percentage change in quarterly revenue confirms the business's resilience, where the current status equals 15.80. Growth is driven by robotic thrombectomy systems that streamline physician workflows. The company's stability relies on a strong team of R&D engineers dedicated to the mission of saving lives and innovative development.

PEN (Penumbra Inc) Quarterly Sales Growth history from 07/04/2022 to 11/20/2026

Penumbra Corp - analytical breakdowns and key metrics (PEN)

- stock price and consensus target price:
- business market valuation indicators:
- cash and cash movement details:
General company analysis:Penumbra Inc (PEN)
Mass-produced product of Penumbra Inc

Inelastic demand for Penumbra, Inc. (PEN) emergency devices ensures high cash flow predictability. This quarterly revenue growth chart measures the percentage change in sales volume of the current quarter compared to the same period last year, reflecting capital inflow dynamics. The current value of 15.80 allows for an assessment of business scaling rates relative to market peaks. The stable trend of this indicator confirms the asset's fundamental resilience to economic crises.

Main competitors

DexCom Inc - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Novanta Inc.|HAE: Quarterly Revenue Growth|Sales Growth QoQ INSP|PRCT (Procept) - Quarterly Revenue Growth|CONMED Corp. (CNMD) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PLSE|Quarterly Sales Growth InMode Ltd. INMD|Revenue Growth QoQ Picard Medical PMI|Quarterly Revenue Growth Surmodics Inc SRDX|SENS - Revenue Growth QoQ|NPCE: Revenue Growth QoQ|TCMD (Tactile Systems Technology Inc.) - Quarterly Sales Growth|Sanuwave Health Inc - Quarterly Revenue Increase|Quarterly Sales Growth OM|Quarterly Revenue Growth Rate smartvest.com ELMD|Revenue Growth QoQ LENSAR Inc. (LNSR)|AVITA Medical, Inc. (RCEL) - Revenue Change vs Previous Quarter|Profound Medical Corp - Quarterly Sales Growth|Quarterly Revenue Growth Baird Medical Corp BDMD|EDAP TMS SA - Quarterly Revenue Growth|Quarterly Sales Growth Rate Apyx Medical Corporation APYX|IceCure Medical (ICCM) - Revenue Growth QoQ|Revenue Dynamics QoQ LUNG (Pulmonx Corp.)|Revenue Growth QoQ telabio.com|Quarterly Sales Growth Cytosorbents (CTSO)|Quarterly Revenue Growth SRTS|ZYXI - Quarterly Revenue Growth Rate|Revenue Growth QoQ electrocore.com ECOR|RBOT: Sales Growth QoQ|IINN: Quarterly Sales Growth|Quarterly Sales Growth Rate SeaStar Medical Holding ICU|IRIX: Quarterly Revenue Growth|INBS - Quarterly Sales Growth Rate|XAIR (Beyond Air Inc) - Quarterly Revenue Growth|PFSA: Quarterly Revenue Increase|Revenue Growth QoQ STRATA Skin Sciences Inc. (SSKN)|Quarterly Revenue Growth GlucoTrack, Inc. (GCTK)|Revenue Growth QoQ nanovibronix.com NAOV|Quarterly Revenue Growth Venus Concept Inc VERO|NUWE - Revenue Growth QoQ|AEMD: Revenue Growth QoQ|ASXC (Asensus Surgical) - Quarterly Sales Growth|Quarterly Revenue Growth Rate avinger.com (AVGR)|Quarterly Sales Growth BSGM|CUTR: Quarterly Revenue Increase|Revenue Growth QoQ Know Labs Corporation (KNW)|NARI - Quarterly Revenue Growth Rate|Revenue Growth QoQ Nevro Corp. NVRO|ReShape Lifesciences Inc - Revenue Growth QoQ|SILK: Quarterly Sales Growth